Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing sotagliflozin to placebo in Chinese patients with type 2 diabetes not adequately controlled by diet and exercise; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED